Shigebumi Tanaka

Prognostic significance of L-type amino acid transporter 1 expression in resectable stage I–III nonsmall cell lung cancer

Kyoichi Kaira, Noboru Oriuchi, Hisao Imai et al. · British Journal of Cancer · 2008 · 214 citations · Full text

Medicine, Cancer Biology, Oncology +15

<scp>l</scp>‐type amino acid transporter 1 and CD98 expression in primary and metastatic sites of human neoplasms

Kyoichi Kaira, Noboru Oriuchi, Hisao Imai et al. · Cancer Science · 2008 · 160 citations · Full text

Medicine, Cancer Biology, Oncology +16

The clinical significance of Cyclin B1 and Wee1 expression innon-small-cell lung cancer

Teruhiko Yoshida, Shigebumi Tanaka, Akira Mogi et al. · Annals of Oncology · 2004 · 141 citations · Full text

Medicine, Cell Biology, Oncology +16

Phase II prospective study of the efficacy of gefitinib for the treatment of stage III/IV non-small cell lung cancer with EGFR mutations, irrespective of previous chemotherapy

Noriaki Sunaga, Yoshio Tomizawa, Noriko Yanagitani et al. · Lung Cancer · 2007 · 129 citations

Medicine, Oncology, Pharmacology +16

Fluorine-18-α-Methyltyrosine Positron Emission Tomography for Diagnosis and Staging of Lung Cancer: A Clinicopathologic Study

Kyoichi Kaira, Noboru Oriuchi, Yoshimi Otani et al. · Clinical Cancer Research · 2007 · 110 citations

Medicine, Nuclear Medicine, Oncology +17